• Today
    July 15

  • 12:56 PM

Wales and Ellerton to battle for $50 000 in Capelli Cup final

Nick Maitland,

Added 01 December 2019


Shakille Belle is expected to be the main man for Ellerton. (FILE)

All eyes will be fixed on theWildey Turf tonight when Crane & Equipment Ellerton take on Weymouth Wales battle for a grand prize of $50 000 in the final of the inaugural Capelli Sport Super Cup.

Ellerton have notched seven wins en route to the final, notably two eight-goal performances over Checker Hall and Villa United and a nine-goal annihilation of Youth Milan, which contributed to almost 80 per cent of their 34 goals.

Shakille Belle has been an obvious danger man, with ten goals from his side’s seven games but the goalscoring exploits of teammate Shaquan Clarke should not be overlooked.

Wales, on the other hand, are on a run of eight consecutive wins after playing one game more than Ellerton in the group phase. 

They have been efficient in all areas of the pitch, with goal and assist contributions shared rather evenly throughout the squad. The Carrington Village side are the reigning BFA Champions Cup winners and last won the Premier League in 2018. (NM)


Dos and Donts

Welcome to our discussion forum here on nationnews.com. We encourage lively debate, but we also urge you to take note of the following:

  • Stay on topic – This helps keep the thread focused on the discussion at hand. If you would like to discuss another topic, look for a relevant article.
  • Be respectful – Meeting differences of opinion with civil discussion encourages multiple perspectives and a positive commenting environment.
  • Do not type in capitals – In addition to being considered “shouting” it is also difficult to read.
  • All comments will be moderated – Given the volume of comments each day, this may take some time. So please be patient.
  • We reserve the right to remove comments – Comments that we find to be abusive, spam, libellous, hateful, off-topic or harassing may be removed.
  • Reproduction of comments – Some of your comments may be reproduced on the website or in our daily newspapers. We will use the handle, not your email address.
  • Do not advertise – Please contact our Advertising Department.
  • Contact our Online Editor if you have questions or concerns.
  • Read our full Commenting Policy and Terms of Use.
comments powered by Disqus


Would you take an approved vaccine for COVID-19?